$BPMC has seen a notable increase in its stock price, gapping up by 6% and rising to a 10% gain following a positive note from Morgan. The stock has attracted significant interest, with many short puts in open interest. Analysts and traders are expressing strong bullish sentiment towards $BPMC, with one trader maintaining a long-term target of $150 to $180. The stock's momentum continues as it remains strong near highs, particularly in the context of the ongoing JPM Healthcare Conference. Other biotech stocks, including $AMGN, are also performing well, with $AMGN reaching new highs after recent bullish trading activity. Overall, the biotech sector appears to be thriving as it heads into the conference.